| scholarly article | Q13442814 |
| P50 | author | Bradford G. Hill | Q37381688 |
| Roberto Bolli | Q56166630 | ||
| Detlef Obal, M.D., Ph.D., D.E.S.A. | Q64948848 | ||
| P2093 | author name string | Matthew B West | |
| Yu-Ting Xuan | |||
| Aruni Bhatnagar | |||
| Daniel J Conklin | |||
| Sumanth D Prabhu | |||
| Jay L Zweier | |||
| Murugesan Velayutham | |||
| Rachel J Keith | |||
| Gregg Rokosh | |||
| Yiru Guo | |||
| Jürgen Schrader | |||
| Detlef Obal | |||
| P2860 | cites work | Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury | Q24323877 |
| The nitric oxide hypothesis of late preconditioning | Q28290101 | ||
| Mitochondrial control of cell death | Q29617739 | ||
| Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. | Q30329252 | ||
| Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor | Q30453517 | ||
| The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene | Q30454405 | ||
| Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. | Q31552541 | ||
| The late phase of preconditioning | Q33926118 | ||
| Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology | Q33972677 | ||
| Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: implications in health and disease | Q34101082 | ||
| Does nitric oxide modulate mitochondrial energy generation and apoptosis? | Q34127186 | ||
| Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research | Q34439279 | ||
| The mitochondrial death/life regulator in apoptosis and necrosis | Q34465435 | ||
| Role of the mitochondrial permeability transition in myocardial disease | Q35204734 | ||
| Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection | Q35625497 | ||
| Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection | Q35666876 | ||
| The role of oxidants and free radicals in reperfusion injury | Q36437576 | ||
| Demonstration of an early and a late phase of ischemic preconditioning in mice | Q36982103 | ||
| Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism | Q36982154 | ||
| Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. | Q38357891 | ||
| Structural changes in myocardium during acute ischemia. | Q39946383 | ||
| Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion | Q41977320 | ||
| Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction | Q43851357 | ||
| Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? | Q44088292 | ||
| Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart | Q44401253 | ||
| Preconditioning delays Ca2+-induced mitochondrial permeability transition | Q44734187 | ||
| Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. | Q44764287 | ||
| Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection | Q44832208 | ||
| Preconditioning improves postischemic mitochondrial function and diminishes oxidation of mitochondrial proteins | Q44926081 | ||
| Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury | Q45255900 | ||
| Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. | Q53918295 | ||
| Nitric Oxide Inhibits Caspase-3 byS-Nitrosationin Vivo | Q63303725 | ||
| Nitric Oxide Inhibition of Lipid Peroxidation: Kinetics of Reaction with Lipid Peroxyl Radicals and Comparison with α-Tocopherol† | Q63676968 | ||
| Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury | Q71763431 | ||
| Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate | Q78020301 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mitochondrion | Q39572 |
| reperfusion injury | Q1413991 | ||
| P304 | page(s) | 1970-1978 | |
| P577 | publication date | 2008-10-20 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition | |
| P478 | volume | 118 |
| Q34120490 | Adjuvant cardioprotection in cardiac surgery: update. |
| Q42037299 | Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor |
| Q35994125 | Altered expression of mitochondrial electron transport chain proteins and improved myocardial energetic state during late ischemic preconditioning |
| Q89482547 | An emerging perspective on sex differences: Intersecting S-nitrosothiol and aldehyde signaling in the heart |
| Q34591282 | Animal models of cardiovascular diseases |
| Q46328269 | Baicalein Preventive Treatment Confers Optimal Cardioprotection by PTEN/Akt/NO Activation |
| Q37576051 | Bench-to-bedside review: nitric oxide in critical illness--update 2008. |
| Q84393642 | Between nitros(yl)ation and nitration: regulation of thioredoxin-1 in myocardial ischemia/reperfusion injury |
| Q40250067 | Carbon monoxide increases inducible NOS expression that mediates CO-induced myocardial damage during ischemia-reperfusion |
| Q42145276 | Cardiac myocyte-specific transgenic ecSOD targets mitochondria to protect against Ca(2+) induced permeability transition |
| Q36420890 | Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
| Q47316917 | Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice. |
| Q33776986 | Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis |
| Q54977073 | Connexins and Nitric Oxide Inside and Outside Mitochondria: Significance for Cardiac Protection and Adaptation. |
| Q43182602 | Cyclosporine A-induced nitration of tyrosine 34 MnSOD in endothelial cells: role of mitochondrial superoxide |
| Q34219629 | Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common beta-chain heteroreceptor |
| Q51695091 | Enhanced stem cell-derived cardiomyocyte differentiation in suspension culture by delivery of nitric oxide using S-nitrosocysteine. |
| Q39419369 | Environmental Determinants of Cardiovascular Disease |
| Q36862431 | Genetic Deficiency of Glutathione S-Transferase P Increases Myocardial Sensitivity to Ischemia-Reperfusion Injury. |
| Q40257008 | Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury |
| Q33671918 | Inhibition of inducible nitric oxide synthase prevents mitochondrial damage and improves survival of steatotic partial liver grafts |
| Q40844657 | Involvement of nitric oxide in a rat model of carrageenin-induced pleurisy |
| Q37668843 | Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists |
| Q35218899 | Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism |
| Q36516680 | Later phase cardioprotection of ischemic post-conditioning against ischemia/reperfusion injury depends on iNOS and PI3K-Akt pathway |
| Q48194167 | Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure. |
| Q37379567 | Loss of cardioprotection with ageing. |
| Q38120093 | Molecular mechanisms of ischemic conditioning: translation into patient outcomes |
| Q34716489 | Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS. |
| Q34424756 | Netrin-1 improves post-injury cardiac function in vivo via DCC/NO-dependent preservation of mitochondrial integrity, while attenuating autophagy |
| Q37556067 | Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart |
| Q49501122 | Nitric oxide signalling in cardiovascular health and disease. |
| Q26830146 | Nitric oxide synthases in heart failure |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q54944917 | Nitrite as a pharmacological intervention for the successful treatment of crush syndrome. |
| Q26747626 | Oxidative-Nitrosative Stress and Myocardial Dysfunctions in Sepsis: Evidence from the Literature and Postmortem Observations |
| Q49477845 | Piecewise nonlinear mixed-effects models for modeling cardiac function and assessing treatment effects. |
| Q34074329 | Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids |
| Q35631788 | Protein S-glutathiolation: redox-sensitive regulation of protein function. |
| Q30385401 | Protein S-nitrosylation and cardioprotection |
| Q35165194 | Reactive oxygen species in cardiovascular disease. |
| Q36205698 | Redox mechanisms of cardiomyocyte mitochondrial protection |
| Q34170269 | Regulation of mitochondrial processes by protein S-nitrosylation |
| Q38771646 | Repeated ischaemic preconditioning: a novel therapeutic intervention and potential underlying mechanisms |
| Q37996857 | Rodent models of heart failure: an updated review. |
| Q36084089 | Role of inducible nitric oxide synthase in mitochondrial depolarization and graft injury after transplantation of fatty livers |
| Q48119761 | Roles of Endoplasmic Reticulum Stress in NECA-Induced Cardioprotection against Ischemia/Reperfusion Injury. |
| Q36824230 | Roles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts |
| Q43994078 | Roles of mitochondrial Src tyrosine kinase and zinc in nitric oxide-induced cardioprotection against ischemia/reperfusion injury |
| Q36473769 | Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury |
| Q58579766 | Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q38565004 | Strategies to increase nitric oxide signalling in cardiovascular disease |
| Q37429016 | Sulindac confers high level ischemic protection to the heart through late preconditioning mechanisms |
| Q28073279 | Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases |
| Q52601421 | Taxol, a microtubule stabilizer, improves cardiac functional recovery during postischemic reperfusion in rat in vitro. |
| Q36109838 | The COX-2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late phase of ischemic preconditioning |
| Q33582810 | The valosin-containing protein is a novel mediator of mitochondrial respiration and cell survival in the heart in vivo |
| Q33917095 | Therapeutic hypothermia cardioprotection via Akt- and nitric oxide-mediated attenuation of mitochondrial oxidants |
| Q39014895 | Toll-like receptor 7/8 agonist resiquimod induces late preconditioning in neonatal cardiac myocytes |
| Q38318626 | Trans-system mechanisms against ischemic myocardial injury |
| Q37951856 | Usefulness of combining intermittent hypoxia and physical exercise in the treatment of obesity. |
| Q36099938 | What makes the mitochondria a killer? Can we condition them to be less destructive? |
| Q83179013 | [Ischemic heart disease: 2009 update] |
| Q34092872 | eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex. |
Search more.